Categorize the input news's emotional tone into one of three groups.
Options: negative, positive

Amgen's (AMGN) KRAS inhibitor, Lumakras, gets approval in Japan for the treatment of KRAS G12C-mutated positive advanced/recurrent non-small-cell lung cancer.
positive